ask="49.35"
ask_size="100"
average_daily_volume="1152360"
bid="36.12"
bid_size="200"
book_value="10.71"
change="-0.07"
change_from_200_day_moving_average="-4.70"
change_from_50_day_moving_average="5.92"
change_from_52_week_high="-33.09"
change_From_52_week_low="15.64"
change_in_percent="-0.15%"
close="47.02"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.79"
ebitda="-408.44M"
eps_estimate_current_year="-5.01"
eps_estimate_next_quarter="-1.30"
eps_estimate_next_year="-4.66"
ex_dividend_date="N/A"
float_shares="70964000"
high="48.33"
high_52_weeks="80.11"
last_trade_date="2/16/2017"
last_trade_price="47.02"
last_trade_size="N/A"
last_trade_time="4:00pm"
low="46.41"
low_52_weeks="31.38"
market_capitalization="4.04B"
moving_average_200_day="51.72"
moving_average_50_day="41.10"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="62.73"
open="46.97"
pe_ratio="N/A"
peg_ratio="-0.20"
percent_change_from_200_day_moving_average="-9.09%"
percent_change_from_50_day_moving_average="+14.40%"
percent_change_from_52_week_high="-41.31%"
percent_change_from_52_week_low="+49.84%"
previous_close="47.09"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.40"
price_per_sales="85.77"
revenue="47.16M"
shares_outstanding="85900000"
short_ratio="10.08"
stock_exchange="NMS"
symbol="ALNY"
volume="870124"
weeks_range_52="31.38 - 80.11"
